Wegovy is only approved for obesity in India. Novo Nordisk has no immediate plans to launch Ozempic for type 2 diabetes, though it is exploring oral semaglutide for obesity.

Novo Nordisk has officially launched its anti-obesity drug Wegovy in India ahead of patent expiry. This move aims to tackle rising obesity rates while facing competition from rival drugs.

Susan had tried diets before without success, but says one audio programme has seen her lose a third of her weight in under ...

Irrespective of what we don’t know, the advent of Mounjaro as a substitute for self-control and willpower is entirely in keeping with our labour-saving, quick-fix culture. Why worry when we now have ...

Mounjaro has been accessible in specialist NHS weight loss clinics since March. Another weight loss medication, Wegovy, also ...

While both drugs belong to the GLP-1 receptor agonist class, Mounjaro has a dual mechanism (GIP and GLP-1), which clinical ...

A new trial has found that a weight loss drug taken monthly helps people lose 20 percent of their body weight. Weight loss ...

Ahead of the launch, the firm has taken steps to amplify its production capacities to ensure adequate supply, and believes ...

It’s a shot at better health that comes with a promise to help shed the pounds. Demand for drugs like Ozempic, Wegovy, Mounjaro and Zepbound continues to grow. FILE – Donna ...

The achievement of that goal in India, which ranks third in obesity numbers after the US and China, will shatter the record ...

As weight loss medication became mainstream news, GP surgeries have reported being inundated with requests for the jabs. With ...